11![Published OnlineFirst September 22, 2009; DOI:[removed].CCR[removed]Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Hardev S. Pandha, Lucy Heinemann, Guy R. Simp](https://www.pdfsearch.io/img/61916b2e871aac75ce4dce8cf74b3481.jpg "Published OnlineFirst September 22, 2009; DOI:[removed].CCR[removed]Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Hardev S. Pandha, Lucy Heinemann, Guy R. Simp") | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 12:38:23
|
|---|
12![DOI:[removed].CCR[removed]Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy Katie Twigger, Laura Vidal, Christine L. White, et al. Clin Cancer Res 2008;14:[removed]Published online](https://www.pdfsearch.io/img/f4d5223a336a4aeb92b7061fdb5bb41a.jpg "DOI:[removed].CCR[removed]Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy Katie Twigger, Laura Vidal, Christine L. White, et al. Clin Cancer Res 2008;14:[removed]Published online") | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-24 04:27:08
|
|---|
13![Published OnlineFirst October 6, 2010; DOI:[removed].CCR[removed]REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer Charles Comins, James Spicer, Andrew Protheroe, et](https://www.pdfsearch.io/img/65e975fe043f3a3ea6397dba6a8790e4.jpg "Published OnlineFirst October 6, 2010; DOI:[removed].CCR[removed]REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer Charles Comins, James Spicer, Andrew Protheroe, et") | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 11:19:21
|
|---|
14 | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 11:30:37
|
|---|
15 | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 12:40:40
|
|---|
16![Heinemann et al. BMC Cancer 2011, 11:221 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access](https://www.pdfsearch.io/img/85401678d7ccfffd6d1cdc9e2d494787.jpg "Heinemann et al. BMC Cancer 2011, 11:221 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access") | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2013-12-23 11:49:37
|
|---|
17![Microsoft PowerPoint - Investor Presentation August[removed]Read-Only]](https://www.pdfsearch.io/img/514f107cf770697836bbe6bd45c2bea3.jpg "Microsoft PowerPoint - Investor Presentation August[removed]Read-Only]") | Add to Reading ListSource URL: www.oncolyticsbiotech.comLanguage: English - Date: 2014-08-18 11:01:12
|
|---|
18![501 Elliott Ave. W. #400 Seattle, WA[removed]T[removed]F[removed]](https://www.pdfsearch.io/img/e2fa40691bbf6546adbdeaf7cdccbae0.jpg "501 Elliott Ave. W. #400 Seattle, WA[removed]T[removed]F[removed]") | Add to Reading ListSource URL: www.gog.orgLanguage: English - Date: 2006-04-19 19:00:49
|
|---|
19![BIOTECHNOLOGY
INDUSTRY
LEADER
MARK
LIEVONEN
HONOURED
Induction
to
the
Canadian
Marketing
Healthcare
Hall
of
Fame
[OTTAWA] April 11, 2013 – On beh](https://www.pdfsearch.io/img/1ac01ccffbe82e5f3aa2f83137bcfc3a.jpg "BIOTECHNOLOGY
INDUSTRY
LEADER
MARK
LIEVONEN
HONOURED
Induction
to
the
Canadian
Marketing
Healthcare
Hall
of
Fame
[OTTAWA] April 11, 2013 – On beh") | Add to Reading ListSource URL: www.biotech.caLanguage: English - Date: 2013-09-07 17:32:36
|
|---|
20 | Add to Reading ListSource URL: www.psioxus.comLanguage: English - Date: 2011-12-20 03:27:39
|
|---|